No retraction, correction or concern found when last checked on Oct 27, 2026.
Prevalence of Hearing Loss and Hearing Aid Use Among US Medicare Beneficiaries Aged 71 Years and Older
Nicholas S. Reed, Emmanuel E. Garcia-Morales, Clarice Myers and 9 more
JAMA Network Open · 2023
doi:10.1001/jamanetworkopen.2023.26320
Abstract
Question. What is the national prevalence of hearing loss among older US adults?
Findings. In this cohort study of a nationally representative sample of 2803 older adults, 65.3% (representing 21.5 million individuals) of those aged 71 years or older had hearing loss, and by age 90 years, 96.2% of adults had hearing loss. However, only 29.2% of those with hearing loss used hearing aids.
Meaning. These findings suggest that hearing loss among the oldest old adults (ie, aged ≥80 years) is more pervasive than previously thought and warrants deeper consideration of discrete severity measures of hearing loss in this population, rather than binary hearing loss terminology.
Importance. National prevalence estimates are needed to guide and benchmark initiatives to address hearing loss. However, current estimates are not based on samples that include representation of the oldest old US individuals (ie, aged ≥80 years), who are most at-risk of having hearing loss.
Objective. To estimate the prevalence of hearing loss and hearing aid use by age and demographic covariates in a large, nationally representative sample of adults aged 71 years and older.
Design, Setting, and Participants. In this cohort study, prevalence estimates of hearing loss by age, gender, race and ethnicity, education, and income were computed using data from the 2021 National Health Aging and Trends Study. Survey weights were applied to produce nationally representative estimates to the US older population. Data were collected from June to November 2021 and were analyzed from November to December 2022.
Main Outcomes and Measures. Criterion-standard audiometric measures of hearing loss and self-reported hearing aid use.
Results. In this nationally representative sample of 2803 participants (weighted estimate, 33.1 million individuals) aged 71 years or older, 38.3% (95% CI, 35.5%-41.1%) were aged 71 to 74 years, 36.0% (95% CI, 33.1%-38.8%) were aged 75 to 79 years, 13.8% (95% CI, 12.6%-14.9%) were aged 80 to 84 years, 7.9% (95% CI, 7.2%-8.6%) were aged 85 to 89 years, and 4.0% (95% CI, 3.5%-4.6%) were aged 90 years or older; 53.5% (95% CI, 50.9%-56.1%) were female and 46.5% (95% CI, 43.9%-49.1%) were male; and 7.5% (95% CI, 6.2%-8.7%) were Black, 6.5% (95% CI, 4.4%-8.7%) were Hispanic, and 82.7% (95% CI, 79.7%-85.6%) were White. An estimated 65.3% of adults 71 years and older (weighted estimate, 21.5 million individuals) had at least some degree of hearing loss (mild, 37.0% [95% CI, 34.7%-39.4%]; moderate, 24.1% [95% CI, 21.9%-26.4%]; and severe, 4.2% [95% CI, 3.3%-5.3%]). The prevalence was higher among White, male, lower-income, and lower education attainment subpopulations and increased with age, such that 96.2% (95% CI, 93.9%-98.6%) of adults aged 90 years and older had hearing loss. Among those with hearing loss, only 29.2% (weighted estimate, 6.4 million individuals) used hearing aids, with lower estimates among Black and Hispanic individuals and low-income individuals.
Conclusions and Relevance. These findings suggest that bilateral hearing loss is nearly ubiquitous among older US individuals, prevalence and severity increase with age, and hearing aid use is low. Deeper consideration of discrete severity measures of hearing loss in this population, rather than binary hearing loss terminology, is warranted.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Hearing loss has gained public health interest as an important factor affecting healthy aging. It is associated with cognitive decline, impaired physical function, poorer health resource utilization, and dementia. Importantly, evidence suggests that hearing treatment may mitigate these associations and prevent poor health outcomes,, spurring federal agency actions and Congressional legislation to address hearing loss in the US., To this end, accurate and complete national hearing loss prevalence estimates are important for public health planning and understanding.
However, nationally representative estimates of hearing loss among older adults, particularly those older than 80 years, are limited. National estimates are from the National Health and Nutritional Examination Surveys (NHANES), nearly a decade old, and not proactively sampled to include a representative sample of the oldest old (ie, aged ≥80 years). NHANES data collection methods may also pose barriers for those with travel restrictions or who are homebound, excluding their participation.,, Other commonly used national estimates of hearing loss are based on self-reports, that may lack sensitivity and specificity compared with criterion-standard hearing measures, especially for older adults, who tend to underestimate their level of hearing loss.
The National Health and Aging Trends Study (NHATS) is a large, nationally representative panel study of Medicare beneficiaries aged 65 years and older with robust oversampling of the oldest old. Following a 2019 pilot, the 2021 NHATS round 11 protocol added pure-tone audiometry, the criterion standard for quantifying audiometric hearing loss, in addition to already collected self-reported hearing aid use. Using these data, we present the largest and most recent epidemiological estimates of measured hearing loss and hearing aid use among older adults in the US.
Study Participants
NHATS is a nationally representative longitudinal panel study of Medicare beneficiaries aged 65 years and older in the continental US (NHATS does not recruit in Alaska, Hawaii, or US territories such as Puerto Rico) begun in 2011. Although initial sampling was among community-dwelling adults, annual follow-up interviews are completed regardless of residential status (eg, institutional residence). The last sample replenishment occurred in 2015; hence, the current participants are aged 71 years and older. NHATS oversamples by age and race to provide statistical power for analyses of commonly underrepresented populations and uses in-home visits to overcome travel restrictions. NHATS data are publicly available. Data collection protocols were approved by the Johns Hopkins University institutional review board, and all participants provided informed consent. This cohort study follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines for observational studies.
In round 11 of NHATS, 2803 of 3817 surveyed participants completed the hearing measures. Participants without hearing measures were excluded from the final estimates. For estimates stratified by demographic and socioeconomic variables, an additional 30 participants had data missing for race or ethnicity, 26 had data missing for education level, and 2 had income data missing.
Hearing Measurement
Pure-tone air conduction audiometry was conducted in participants’ homes using an iPad (Apple)–based portable audiometer (SHOEBOX Ltd) with sound-attenuating Sennheiser DD450 headphones., Trained technicians used a software-assisted algorithm that mimics clinical best-practice guidelines to identify the lowest volume, measured in decibels hearing level (dBHL), at which a participant could reliably respond to the presented tones. Data were collected in each ear at 0.5, 1.0, 2.0, 4.0, and 8.0 kHz. Before and during the assessment, the audiometer software continuously monitors the ambient environmental noise to ensure that noise levels do not interfere with validity of the assessment. In addition, the software monitors responses for false-positives and flags implausible or rare results.
Consistent with previous population-level definitions of hearing loss, a pure-tone average of the frequencies most important for speech understanding (0.5, 1.0, 2.0, and 4.0 kHz) was derived for the better-hearing ear (ie, hearing loss in both ears) and worse-hearing ear (ie, hearing loss in at least 1 ear). We categorized pure-tone average using the clinical cut points most used in population-level research (no hearing loss, ≤25 dBHL; mild, 26-40 dBHL; moderate, 41-60; and severe or greater, >60 dBHL).,,, In sensitivity analyses, we categorized pure-tone average using the recently adopted World Health Organization categories (no hearing loss, <20 dBHL; mild, 20-34.9 dBHL; moderate, 35-49.9 dBHL; moderately severe, 50-64.9 dBHL; severe or greater, ≥65 dBHL). Hearing aid use was defined by the question, “In the last month, have you used a hearing aid or other hearing device?” with yes or no as the answer.
Covariates
Age was categorized in 5-year bins (71-74, 75-79, 80-84, 85-89, and ≥90 years). Sociodemographic covariates included self-reported gender (female and male), race and ethnicity (Black, non-Hispanic; Hispanic; and White, non-Hispanic, hereafter referred to as Black, Hispanic, and White, respectively), highest education level (high school or less, some college, and college diploma or more), and income with respect to the Federal Poverty Level (FPL) for a household with at least 2 people aged 65 years or older (<100% FPL, 100%-200% FPL, and >200% FPL).
Statistical Analysis
We compared differences in demographic and socioeconomic variables between NHATS participants who did and did not complete hearing assessment using χ2 tests (categorical variables) and Kruskal-Wallis analysis of variance (continuous variables) to understand how well the analytic sample represents the entire study sample and inform interpretation (generalizability) of findings. Statistical significance was set at 2-sided P <.05. Next, among those with hearing measures, we estimated the prevalence of better-ear hearing loss (ie, hearing loss in both ears) among adults aged 71 years and older by demographic and socioeconomic variables by standardizing weighted prevalence estimates by age and gender to the population aged 71 years and older living in the continental US using data from the 2020 Census Bureau, American Community Survey, per NHATS guidelines., Overall prevalence estimates were calculated by all 5-year age strata. However, because of limitations in Census estimates and minimum cell size requirements, estimates that were further stratified by other demographic variables, as well as reporting of absolute number (in millions), were restricted to ages 71 to 74, 75 to 79, 80 to 84, and 85 or older years. Subsequent analyses estimated national prevalence of hearing loss by better-hearing and worse-hearing ear by age category and by hearing severity (better-ear) by age category. Finally, we calculated prevalence estimates of hearing aid use for adults aged 71 years and older with hearing loss. Population numbers were calculated from the estimated population of older adults in the continental US extrapolating the estimated prevalence of hearing loss among NHATS participants.
NHATS weights are calculated to account for differential probabilities of selection and nonresponse, and survey design, to make nationally representative parameter estimates. Analyses used round 11 survey weights. Data were collected from June to November 2021 and were analyzed from November to December 2022 using Stata statistical software version 17 (StataCorp).
Results
Compared with 2803 participants who completed hearing testing, 1014 participants who did not complete testing were older (4.0% [3.5%-4.6%] vs 13.5% [95% CI, 10.5%-16.5%] were aged ≥90 years), more likely to be Black (7.5% [95% CI, 6.2%-8.7%] vs 9.9% [95% CI, 7.6%-12.3%]) or Hispanic (6.5% [95% CI, 4.4%-8.7%] vs 8.4% [95% CI, 5.2%-11.6%]), and more likely to have lower income levels (11.3% [95% CI, 9.5%-13.1%] vs 30.2% [95% CI, 25.0%-35.4%] had incomes <100% FPL) (Table 1). Our analytic sample included 2803 NHATS participants (2620 community dwelling and 183 institutionalized), representing 33.1 million adults aged 71 years and older. In the weighted sample, 38.3% (95% CI, 35.5%-41.1%) were aged 71 to 74 years, 36.0% (95% CI, 33.1%-38.8%) were aged 75 to 79 years, 13.8% (95% CI, 12.6%-14.9%) were aged 80 to 84 years, 7.9% (95% CI, 7.2%-8.6%) were aged 85 to 89 years, and 4.0% (95% CI, 3.5%-4.6%) were aged 90 years and older; 53.5% (95% CI, 50.9%-56.1%) were female and 46.5% (95% CI, 43.9%-49.1%) were male; and 7.5% (95% CI, 6.2%-8.7%) were Black, 6.5% (95% CI, 4.4%-8.7%) were Hispanic, and 82.7% (95% CI, 79.7%-85.6%) were White. By education, 35.0% (95% CI, 31.5%-38.5%) completed high school or less, 30.2% (95% CI, 27.4%-33.0%) completed some college, and 34.9% (95% CI, 30.8%-39.0%) completed college or advanced degrees. Finally, 11.3% (95% CI, 9.5%-13.1%) had incomes less than 100% of the FPL, 21.9% (95% CI, 19.2%-24.5%) had incomes 100% to 200% of the FPL, and 66.8% (95% CI, 63.5%-70.1%) had incomes greater than 200% of the FPL.
In weighted analyses, 65.3% (95% CI, 62.2%-68.4%), or approximately 7 in 10, of adults aged 71 years and older had hearing loss (mild, 37.0% [95% CI, 34.7%-39.4%]; moderate, 24.1% [95% CI, 21.9%-26.4%]; and severe, 4.2% [95% CI, 3.3%-5.3%]) in the better ear (ie, hearing loss in both ears), representing an estimated 21.5 million individuals. Prevalence estimates were higher when using a worse-ear (ie, loss in at least 1 ear) definition (78.1%; 25.8 million individuals). When the newly adopted World Health Organization thresholds were applied, the prevalence of hearing loss increased such that 8 in 10 US individuals aged 71 years and older had hearing loss (eTable 1 in Supplement 1). Overall, the prevalence of hearing loss increased with age. Among those aged 80 years or older, 35.8% (95% CI, 32.8%-38.9%) had mild hearing loss, 38.8% (95% CI, 35.3%-42.3%) had moderate hearing loss, and 9.6% (95% CI, 8.1%-11.3%) had severe or greater hearing loss. In specific age strata, 53.4% (95% CI, 47.2%-59.6%; 6.0 million individuals) of participants aged 71 to 74 years had hearing loss compared with 76.7% (95% CI, 73.1%-80.3%; 6.2 million individuals) of participants aged 80 to 85 years, 91.0% (95% CI, 88.1%-93.9%) of participants aged 85 to 90 years, and 96.2% (95% CI, 93.9%-98.6%) of participants aged 90 years and older (5.5 million individuals for those aged ≥85 years). Severity of hearing loss also increased with age. Among adults aged 71 to 74 years, 46.6% (95% CI, 40.4%-52.8%) had normal hearing and 1.8% (95% CI, 0.2%-3.4%) had severe or greater hearing loss, but among those aged 90 years and older, only 3.8% (95% CI, 1.4%-6.1%) had normal hearing and 21.8% (95% CI, 16.8%-26.9%) had severe or greater hearing loss (Table 2 and Figure).
Male participants had a higher overall prevalence of hearing loss (69.7%; 10 million individuals) compared with female participants (61.6%; 11.4 million individuals) (Table 3). However, this difference narrowed with increasing age; the prevalence of hearing loss among participants aged 71 to 75 years was 46.5% of female participants (2.8 million individuals) vs 59.5% of male participants (3.1 million individuals). This difference was not present among participants aged 85 years and older, nearly all of whom had hearing loss (92.3% among female participants [3.5 million individuals] vs 93.8% among male participants [2.0 million individuals]). See eTable 2 in Supplement 1 for absolute number estimates by sociodemographic characteristics.
White participants (67%; 18.3 million individuals) had a higher prevalence of hearing loss compared with Black (55.8%; 1.3 million individuals) and Hispanic (59.3%; 1.2 million individuals) participants. Stratified by age, the difference by race and ethnicity narrowed with increasing age in the overall sample. Among participants aged 71 to 75 years, 55.5% of White (5.2 million individuals) vs 43.3% of Black (0.3 million individuals) participants had hearing loss. However, for participants aged 85 years and older, 93.4% of White participants (4.6 million individuals) vs 84.9% of Black participants (0.3 million individuals) had hearing loss. Prevalence estimates by age were not computed for the Hispanic ethnicity category because there were fewer than 10 observations in some of the age groups. Similar trends were found by education and income levels, whereby a larger proportion of participants with lower education levels and lower income levels had hearing loss in the overall sample, but the gap narrowed with increasing age (Table 3 and eTable 2 in Supplement 1).
Among adults with hearing loss, 29.2% (6.4 million individuals) reported hearing aid use. Use increased with hearing loss severity such that 14.4% (1.7 million individuals) of those with mild, 45.3% (3.6 million individuals) of those with moderate, and 67.9% (0.9 million individuals) of those with severe hearing loss used hearing aids. A higher prevalence of hearing aid use was found among male participants (35.1%; 95% CI, 30.6%-39.9%) vs female participants (23.4%; 95% CI, 20.6%-26.4%), White (32.1%; 95% CI, 29.2%-35.1%) vs Black (8.4%; 95% CI, 5.3%-13.0%) or Hispanic (20.2%; 95% CI, 10.0%-36.7%) participants, and those with higher education and income levels (eTable 3 in Supplement 1); 35.5% (95% CI, 31.8%-3.93%) of those with hearing loss with incomes greater than 200% of the FPL used hearing aids compared with 14.6% (95% CI, 10.6%-19.7%) of those living with incomes less than 100% of the FPL. Hearing aid use also increased with age, with 31.2% (95% CI, 27.3%-35.3%) of adults aged 80 to 85 years and 36.9% (95% CI, 33.2%-40.8%) of those aged 85 years and older using hearing aids.
Discussion
In this cohort study of a nationally representative sample of Medicare beneficiaries, nearly 7 of 10 individuals aged 71 years and older had some degree of hearing loss. Overall prevalence and severity of hearing loss increased with age such that nearly all participants had hearing loss by age 85 years. Nonetheless, less than 30% used hearing aids. To the best of our knowledge, these are the largest and most robust estimates of audiometrically measured hearing among older US individuals to date.
Compared with previous studies in nationally representative data, we report higher prevalence estimates among the oldest old individuals. Estimates from NHANES, which has limited representation over age 80 years, suggested that approximately 66% of individuals older than 70 years and 81% of individuals older than 80 years had hearing loss in the better-hearing ear. Our estimates were similar for those aged 71 years and older but higher for those aged 80 years and older. Likewise, previous estimates using the restricted 80 years and older data in NHANES suggested that 77.2% of those aged 81 to 85 years, 86.1% of those aged 85 to 90 years, and 93.8% of those aged 91 years or older have hearing loss. Our current estimates are slightly higher at 76.7% for those aged 80 to 84 years, 91.0% for those aged 85 to 89 years, and 96.2% for those aged 90 years or older. Estimates by severity were similarly higher in the current analysis (among individuals aged ≥80 years, 35.8% had mild, 38.8% had moderate, and 9.6% had severe or greater hearing loss) compared with previous work in NHANES (among individuals aged ≥80 years, 36.0% had mild, 37.9% had moderate, and 7.53% had severe or greater hearing loss). A possible explanation for the difference, especially among older age groups, is NHATS oversamples and retains underrepresented populations who are more likely to have hearing loss, including the oldest and lower income individuals. In particular, the use of home visits or facility visits for institutionalized participants in NHATS may make assessment and retention more feasible vs use of mobile testing centers in other nationally representative samples.
Our analyses shed light onto the pervasive nature of hearing loss among older adults because nearly all individuals aged 85 years and older have hearing loss. At such high proportions, severity (vs any) becomes important for characterizing hearing among older adults. Clinicians and public health officials should consider moving away from broad binary descriptions of hearing loss, especially among the oldest age groups, toward more granular categories to improve understanding and perceptions of hearing. This shift will also allow for more targeted public health planning and resource allocation, as different degrees of hearing loss may warrant different interventions and programs., Likewise, researchers should consider moving away from binary measurement in this age group to better understand the magnitude of the effect of differing degrees of hearing loss on poor aging outcomes.
Although the categorical definitions for hearing loss used in our study are the most common in population-level research, there is heterogeneity. In a sensitivity analysis, we applied the recently updated World Health Organization hearing loss classifications, which were recommended by an expert panel but lack details on the scientific or clinical basis for the changes. Most notably, the new classifications lowered the threshold for hearing loss from 25 dB to 20 dB. When the World Health Organization thresholds were applied, prevalence of hearing loss increased such that 8 in 10 US individuals aged 71 years and older had hearing loss (eTable 1 in Supplement 1). The nearly ubiquitous nature of hearing loss among older adults may warrant considerations for future work characterizing clinical and epidemiologic cut points specific to older adults according to what levels are important to health outcomes in this population. Importantly, the longitudinal and nationally representative nature of the publicly available NHATS hearing data and robust measures of health important to aging render it a strong data set for future work in this area.
Our study agrees with previous findings,,, that prevalence of hearing loss increases with age and is highest among male, White, and lower-income individuals and those with lower educational attainment. Our findings add to the literature by demonstrating that the differences narrow as age increases. Differences in prevalence of hearing loss by demographic subgroups may be due to differences in life course noise exposure, poorer overall health among economically disadvantaged individuals, and biological factors, including the protective effects of estrogen and melanin in the cochlea.,,, Although these are important considerations for public health interventions (eg, limiting noise exposure) or informing potential pharmacologic interventions to treat or prevent hearing loss (eg, melanin and estrogen), they have little implication for immediate clinical and public health interventions to address hearing loss among older adults. First, we showed that as age increased, the difference in prevalence of hearing loss among demographic subgroups narrowed to nearly no difference. Second, the negative impacts of hearing loss are similar regardless of demographic groups, and the highly prevalent nature of hearing loss warrants scoping public health approaches.
Similar to other studies, hearing aid use was relatively low, at only 29.2% of older adults with hearing loss. Previous estimates using NHANES reported that 17.6% of all adults aged 80 years and older use hearing aids (approximately 22% of those ≥80 years with hearing loss when extrapolating from published tables). Our work limited prevalence estimates to those with hearing loss (eg, at risk for hearing aid use) and found larger proportions of hearing aid use in the strata of those aged 80 years and older: 31.2% for adults aged 80 to 85 years and 36.9% for those aged 85 years and older. Although NHATS’s unique sampling strategy may contribute to differences, the observed increase in proportion of hearing aid owners in this population may also reflect the increasing trend in overall uptake in hearing aids. Our findings that race and ethnicity, education, and income levels were associated with lower prevalence of hearing aid use are consistent with previous studies in representative and population-based samples.,, As use of other technologies (eg, cochlear implants and over-the-counter hearing aids) increase, future work could consider additional questions to further characterize the use of hearing care in the US.
The presented data have implications for recent hearing-focused policy and initiatives. The 2017 Over-the-Counter Hearing Aid Act became official following the US Food and Drug Administration final regulations that created a regulated over-the-counter category of hearing aids for mild-to-moderate hearing loss. In addition, addressing hearing loss to reduce dementia has been added to the National Plan to Address Alzheimer Disease, and Medicare coverage of hearing aids was included in the proposed 2021 Build Back Better bill in the US Congress. Accurate prevalence estimates are essential, because proportional estimates off by just a few percentage points could reflect large differences (on the order of millions of individuals) when extrapolating to absolute numbers for the US population. In the future, larger samples will increase the precision of hearing estimates among the oldest old, but the current data offer a first step in the direction of more accurate estimates.
Limitations
Although there are strengths of NHATS data, including the large sample size and oversampling of older individuals, the analysis has limitations. Groups at the highest risk for hearing loss are more likely to be missing hearing assessment data, which could suggest that the data presented in this analysis underestimate hearing loss prevalence. In addition, current estimates are cross-sectional; nationally representative data on the incidence and timing of hearing loss across the life course are lacking. Future work should provide temporal incidence measures. Moreover, even though NHATS is designed to be nationally representative, there are some limitations in the generalizability. The presented data are only for adults aged 71 years and older because the last replenishment occurred in 2015 (data for individuals aged ≥65 years will be available in the next replenishment scheduled for 2022-2023). Only the continental US states are sampled. Although the NHATS data oversample Black individuals, other racial and ethnic groups are not oversampled because of the relatively low population totals among older individuals. Therefore, we were not able to calculate prevalence estimates beyond White, Black, and Hispanic individuals. However, additional iterations of NHATS will allow for analyses of other subpopulations and racial and ethnic groups. Notably, in keeping with the changing demographics of the US, NHATS plans to oversample Hispanic individuals in the next replenishment. Hearing aid data are in the context of the use of hearing aids in the past month and do not offer details into total length of use or allow for estimates of overall ownership of hearing aids regardless of use, which may be helpful for policy analyses moving forward. The use of income among older adults is limited because it may not fully encapsulate socioeconomic status among older individuals; many are retired and have various sources of wealth. Although efforts are made to include all sources of income among participants, cautious interpretation is warranted. Furthermore, although NHATS offers several first-in-kind estimates in specific demographic groups (eg, adults aged >90 years), there is still imprecision in the estimates owing to the width of the intervals, and caution should be used when applying the estimates.
Conclusions
This study found that approximately two-thirds of adults older than 71 years and nearly all adults older than 85 years have hearing loss, but relatively few use hearing aids. These robust estimates from a nationally representative study that oversamples older adults are higher than previous estimates and provide updated metrics for resource planning related to ongoing and future hearing policy initiatives.
References 28
- 1.
Lin FR, Yaffe K, Xia J,; Health ABC Study Group. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013;173(4):293-299
Not in our library10.1001/jamainternmed.2013.1868
- 2.
Martinez-Amezcua P, Powell D, Kuo PL,. Association of age-related hearing impairment with physical functioning among community-dwelling older adults in the US. JAMA Netw Open. 2021;4(6):e2113742
Not in our library10.1001/jamanetworkopen.2021.13742
- 3.
Reed NS, Altan A, Deal JA,. Trends in health care costs and utilization associated with untreated hearing loss over 10 years. JAMA Otolaryngol Head Neck Surg. 2019;145(1):27-34
Not in our library10.1001/jamaoto.2018.2875
- 4.
Huang AR, Jiang K, Lin FR, Deal JA, Reed NS. Hearing loss and dementia prevalence in older adults in the US. JAMA. 2023;329(2):171-173
Not in our library10.1001/jama.2022.20954
- 5.
Deal JA, Albert MS, Arnold M,. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: results from the Aging and Cognitive Health Evaluation in Elders Pilot Study. Alzheimers Dement (N Y). 2017;3(3):410-415
Not in our library10.1016/j.trci.2017.06.003
- 6.
US Department of Health and Human Services. National plan to address Alzheimer’s Disease: 2021 update. December 27, 2021. Accessed June 23, 2023. https://aspe.hhs.gov/reports/national-plan-2021-update
Not in our library
- 7.
Warren E, Grassley C. Over-the-counter hearing aids: the path forward. JAMA Intern Med. 2017;177(5):609-610
Not in our library10.1001/jamainternmed.2017.0464
- 8.
Sharma RK, Lalwani AK, Golub JS. Prevalence and severity of hearing loss in the older old population. JAMA Otolaryngol Head Neck Surg. 2020;146(8):762-763
Not in our library10.1001/jamaoto.2020.0900
- 9.
Goman AM, Lin FR. Prevalence of hearing loss by severity in the United States. Am J Public Health. 2016;106(10):1820-1822
Not in our library10.2105/ajph.2016.303299
- 10.
Lin FR, Niparko JK, Ferrucci L. Hearing loss prevalence in the United States. Arch Intern Med. 2011;171(20):1851-1852
Not in our library10.1001/archinternmed.2011.506
- 11.
Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. Vital Health Stat 10. 2014;260:1-161.
Not in our library
- 12.
Ries PW. Prevalence and characteristics of persons with hearing trouble, United States, 1990-91. Vital Health Stat 10. 1994;188:1-75.
Not in our library
- 13.
Kamil RJ, Genther DJ, Lin FR. Factors associated with the accuracy of subjective assessments of hearing impairment. Ear Hear. 2015;36(1):164-167
Not in our library10.1097/aud.0000000000000075
- 14.
Freedman VA, Kasper JD. Cohort profile: the National Health and Aging Trends Study (NHATS). Int J Epidemiol. 2019;48(4):1044-1045g
Not in our library10.1093/ije/dyz109
- 15.
Hu M, Freedman VA, Ehrlich JR, Reed NS, Billington C, Kasper JD. Collecting objective measures of visual and auditory function in a national in-home survey of older adults. J Surv Stat Methodol. 2021;9(2):309-334
Not in our library10.1093/jssam/smaa044
- 16.
Thompson GP, Sladen DP, Borst BJH, Still OL. Accuracy of a tablet audiometer for measuring behavioral hearing thresholds in a clinical population. Otolaryngol Head Neck Surg. 2015;153(5):838-842
Not in our library10.1177/0194599815593737
- 17.
Bastianelli M, Mark AE, McAfee A, Schramm D, Lefrançois R, Bromwich M. Adult validation of a self-administered tablet audiometer. J Otolaryngol Head Neck Surg. 2019;48(1):59
Not in our library10.1186/s40463-019-0385-0
- 18.
- 19.
Freedman VA, Spillman BC, Kasper JD. Making national estimates with the National Health and Aging Trends Study. NHATS technical paper #17. November 28, 2016. Revised January 26, 2018. Accessed June 23, 2023. https://nhats.org/sites/default/files/2022-03/Making_National_Estimates_in_NHATS_Technical_Paper_2018_0.pdf
Not in our library
- 20.
Reed NS, Lin FR, Willink A. Changes to Medicare policy needed to address hearing loss. JAMA Health Forum. 2021;2(11):e213582
Not in our library10.1001/jamahealthforum.2021.3582
- 21.
Ferguson MA, Kitterick PT, Chong LY, Edmondson-Jones M, Barker F, Hoare DJ. Hearing aids for mild to moderate hearing loss in adults. Cochrane Database Syst Rev. 2017;9(9):CD012023
Not in our library10.1002/14651858.cd012023.pub2
- 22.
Lin FR, Maas P, Chien W, Carey JP, Ferrucci L, Thorpe R. Association of skin color, race/ethnicity, and hearing loss among adults in the USA. J Assoc Res Otolaryngol. 2012;13(1):109-117
Not in our library10.1007/s10162-011-0298-8
- 23.
Agrawal Y, Platz EA, Niparko JK. Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med. 2008;168(14):1522-1530
Not in our library10.1001/archinte.168.14.1522
- 24.
Helzner EP, Cauley JA, Pratt SR,. Race and sex differences in age-related hearing loss: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(12):2119-2127
Not in our library10.1111/j.1532-5415.2005.00525.x
- 25.
Agrawal Y, Niparko JK, Dobie RA. Estimating the effect of occupational noise exposure on hearing thresholds: the importance of adjusting for confounding variables. Ear Hear. 2010;31(2):234-237
Not in our library10.1097/aud.0b013e3181c6b9fd
- 26.
Reed NS, Garcia-Morales E, Willink A. Trends in hearing aid ownership among older adults in the United States from 2011 to 2018. JAMA Intern Med. 2021;181(3):383-385
Not in our library10.1001/jamainternmed.2020.5682
- 27.
Nieman CL, Marrone N, Szanton SL, Thorpe RJJ Jr, Lin FR. Racial/ethnic and socioeconomic disparities in hearing health care among older Americans. J Aging Health. 2016;28(1):68-94
Not in our library10.1177/0898264315585505
- 28.
Assi L, Reed NS, Nieman CL, Willink A. Factors associated with hearing aid use among Medicare beneficiaries. Innov Aging. 2021;5(3):igab021
Not in our library10.1093/geroni/igab021
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.